Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001231919-24-000093
Filing Date
2024-12-04
Accepted
2024-12-04 08:06:14
Documents
1
Effectiveness Date
2024-12-04
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14964
  Complete submission text file 0001231919-24-000093.txt   16130
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-531031 | Film No.: 241524843
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)